Vertex is faced with an access challenge as it is charging $15.50 for a 50 mg dose of Journavx, which works out to $420 for a two-week course. Generic opioids, meanwhile, go for roughly $0.50 a pill.

Revenue $2.91 billion $2.78 billion $2.52 billion 15.7% Net Income (non-GAAP) $1.04 billion N/A $1.10 billion (5.5%) R&D and SG&A expenses (non-GAAP) $1.21 billion N/A $984 million 22.9% Vertex ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

The science shows us that trees should be planted in zones of no more than 66% impervious surface cover, with 0-32% cover being ideal for the tree’s overall condition. You can use the 'Place to ...

3. Forces tackling in space The depth of the secondary in Cover 4 can leave tons of space underneath for easy completions. Sometimes lots of space can make tackling a twitchy, explosive offensive ...

Q: Our neighbor has a large magnolia tree that casts very heavy shade into ... to grow either turfgrass or hostas there. What ground cover would have the best chance of succeeding?

Vertex' portfolio has been steadily expanded with new product launches to cover the majority of CF mutations, and so it has been looking at new therapeutic categories – including T1D ...

These areas fall under Section 4 of the PLPA, which explicitly prohibits the felling of trees in the revenue areas of Gurgaon, Sohna, and Pataudi tehsils, except for legitimate domestic or ...